Hostname: page-component-6766d58669-fx4k7 Total loading time: 0 Render date: 2026-05-19T16:06:35.206Z Has data issue: false hasContentIssue false
  • English
  • Français

Variability in the antioxidant MSRA gene affects the psychopathology of patients with anorexia nervosa

Published online by Cambridge University Press:  16 August 2021

Luz M González ,
Angustias García-Herráiz ,
Sonia Mota-Zamorano ,
David Albuquerque ,
Isalud Flores  and
Guillermo Gervasini Open the ORCID record for Guillermo Gervasini [Opens in a new window]
Luz M González
Affiliation:
Department of Medical & Surgical Therapeutics, Medical School, University of Extremadura, Badajoz, Spain
Angustias García-Herráiz
Affiliation:
Eating Disorders Unit, Institute of Mental Disorders, Extremadura Health Service, Badajoz, Spain
Sonia Mota-Zamorano
Affiliation:
Department of Medical & Surgical Therapeutics, Medical School, University of Extremadura, Badajoz, Spain
David Albuquerque
Affiliation:
Genomics Group, Fundación Investigación Hospital General Universitario de Valencia, Valencia, Spain
Isalud Flores
Affiliation:
Eating Disorders Unit, Institute of Mental Disorders, Extremadura Health Service, Badajoz, Spain
Guillermo Gervasini*
Affiliation:
Department of Medical & Surgical Therapeutics, Medical School, University of Extremadura, Badajoz, Spain
*
Author for correspondence: Guillermo Gervasini, Email: ggervasi@unex.es
Rights & Permissions [Opens in a new window]

Abstract

The objective is to determine whether variability in the MSRA gene, related to obesity and several psychiatric conditions, may be relevant for psychopathological symptoms common in Anorexia Nervosa (AN) and/or for the susceptibility to the disorder. A total of 629 women (233 AN patients and 396 controls) were genotyped for 14 tag-SNPs. Psychometric evaluation was performed with the EDI-2 and SCL-90R questionnaires. Genetic associations were carried out by logistic regression controlling for age and adjusting for multiple comparisons (FDR method). Two tag-SNPs, rs11249969 and rs81442 (with a pairwise r2 value of 0.41), were associated with the global EDI-2 score, which measures EDI-related psychopathology (adjusted FDR-q = 0.02 and 0.04, respectively). Moreover, rs81442 significantly modulated all the scales of the SCL-90R test that evaluates general psychopathology (FDR-q values ranged from 4.1E-04 to 0.011). A sliding-window analysis using adjacent 3-SNP haplotypes revealed a proximal region of the MSRA gene spanning 187.8 Kbp whose variability deeply affected psychopathological symptoms of the AN patients. Depression was the symptom that showed the strongest association with any of the constructed haplotypes (FDR-q = 3.60E−06). No variants were found to be linked to AN risk or anthropometric parameters in patients or controls. Variability in the MSRA gene locus modulates psychopathology often presented by AN patients.

Keywords

anorexiadepressionMSRApolymorphismspsychopathology

Information

Type
Original Article
Information
Acta Neuropsychiatrica , Volume 33 , Issue 6 , December 2021 , pp. 307 - 316
Check for updates
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of Scandinavian College of Neuropsychopharmacology

Significant outcomes

  • MSRA rs11249969 and rs81442 were significantly associated with ED-related and general psychopathology in the AN patients.

  • Depression was the symptom that showed the strongest association with the identified MSRA haplotypes.

  • Variability in a proximal region in the antioxidant MSRA gene locus profoundly modulated psychopathological symptoms of AN patients.

Limitations

  • The inclusion of more subjects would have been required in the case–control analysis to unequivocally rule out an effect on AN risk.

  • The age of the control subjects was significantly higher than that of the AN patients, which could have partly contributed to the differences in the anthropological parameters.

  • Psychometric scores were not available for the control group.

Introduction

Anorexia Nervosa (AN) is a complex disorder characterised by severe food restriction, fear of weight gain, and body image distortion, all of which leads to the highest mortality rate of any psychiatric disease (Arcelus et al. Reference Arcelus, Mitchell, Wales and Nielsen2011). Traditionally, socio-cultural and family factors have been considered the most important contributors to AN; however, in the last years, twin and family studies have demonstrated the existence of high heritability estimates (Bulik et al. Reference Bulik, Sullivan, Tozzi, Furberg, Lichtenstein and Pedersen2006; Thornton et al. Reference Thornton, Mazzeo and Bulik2011), thus pointing out genetics as a key player in this eating disorder (ED) (Pinheiro et al. Reference Pinheiro, Root and Bulik2009).

The methionine sulfoxide reductase A (MSRA) gene encodes an enzyme (MsrA) that reduces oxidised methionine residues, contributing significantly to the defence against oxidative stress (Kim & Gladyshev Reference Kim and Gladyshev2007). This gene is highly expressed in several areas of the brain and has in fact been related to several psychiatric conditions, such as schizophrenia (Walss-Bass et al. Reference Walss-Bass, Soto-Bernardini, Johnson-Pais, Leach, Ontiveros, Nicolini, Mendoza, Jerez, Dassori, Chavarria-Siles, Escamilla and Raventos2009), bipolar disorder (Ni et al. Reference Ni, Ma, Lin, Lao, Hao, Guan, Li, Jiang, Liu, Ye, Liu, Wang, Zhao, Cao and Li2015) or Alzheimer’s (Gabbita et al. Reference Gabbita, Aksenov, Lovell and Markesbery1999) and Parkinson’s disease (Wassef et al. Reference Wassef, Haenold, Hansel, Brot, Heinemann and Hoshi2007), as well as being associated with a variety of behavioural traits and psychiatric symptoms (Reiterer et al. Reference Reiterer, Schmidt-Kastner and Milton2019). In this regard, various genome-wide association studies (GWAS), replication studies, and meta-analyses (Day et al. Reference Day, Helgason, Chasman, Rose, Loh, Scott, Helgason, Kong, Masson, Magnusson, Gudbjartsson, Thorsteinsdottir, Buring, Ridker, Sulem, Stefansson, Ong and Perry2016; Fan et al. Reference Fan, Wang, Hao, He, Wen, Guo, Wu, Ning, Wang, Wang and Zhang2017; Ma et al. Reference Ma, Deng, Liu, Li, Chen, He, Wang, Wang, Hu, Collier and Li2011; Amare et al. Reference Amare, Schubert, Tekola-Ayele, Hsu, Sangkuhl, Jenkins, Whaley, Barman, Batzler, Altman, Arolt, Brockmoller, Chen, Domschke, Hall-Flavin, Hong, Illi, Ji, Kampman, Kinoshita, Leinonen, Liou, Mushiroda, Nonen, Skime, Wang, Kato, Liu, Praphanphoj, Stingl, Bobo, Tsai, Kubo, Klein, Weinshilboum, Biernacka and Baune2018; Luciano et al. Reference Luciano, Hagenaars, Davies, Hill, Clarke, Shirali, Harris, Marioni, Liewald, Fawns-Ritchie, Adams, Howard, Lewis, Gale, McIntosh and Deary2018; Chu et al. Reference Chu, Liu, Wen, Li, Cheng, Cheng, Zhang, Mei, Qi, Liang, Ye, Kafle, Wu, Wang, Wang, Ning and Zhang2020) have shown that the occurrence of variability in the MSRA gene locus is likely behind the traits and psychiatric conditions observed.

The presence of genetic variants in the MSRA gene has also been linked to obesity. Indeed, three meta-analyses of GWAS have suggested that certain loci in or near this gene are body-mass index (BMI) regulators (Lindgren et al. Reference Lindgren, Heid, Randall, Lamina, Steinthorsdottir, Qi, Speliotes, Thorleifsson, Willer, Herrera, Jackson, Lim, Scheet, Soranzo, Amin, Aulchenko, Chambers, Drong, Luan, Lyon, Rivadeneira, Sanna, Timpson, Zillikens, Zhao, Almgren, Bandinelli, Bennett, Bergman, Bonnycastle, Bumpstead, Chanock, Cherkas, Chines, Coin, Cooper, Crawford, Doering, Dominiczak, Doney, Ebrahim, Elliott, Erdos, Estrada, Ferrucci, Fischer, Forouhi, Gieger, Grallert, Groves, Grundy, Guiducci, Hadley, Hamsten, Havulinna, Hofman, Holle, Holloway, Illig, Isomaa, Jacobs, Jameson, Jousilahti, Karpe, Kuusisto, Laitinen, Lathrop, Lawlor, Mangino, McArdle, Meitinger, Morken, Morris, Munroe, Narisu, Nordstrom, Nordstrom, Oostra, Palmer, Payne, Peden, Prokopenko, Renstrom, Ruokonen, Salomaa, Sandhu, Scott, Scuteri, Silander, Song, Yuan, Stringham, Swift, Tuomi, Uda, Vollenweider, Waeber, Wallace, Walters, Weedon, Witteman, Zhang, Zhang, Caulfield, Collins, Davey Smith, Day, Franks, Hattersley, Hu, Jarvelin, Kong, Kooner, Laakso, Lakatta, Mooser, Morris, Peltonen, Samani, Spector, Strachan, Tanaka, Tuomilehto, Uitterlinden, van Duijn, Wareham, Hugh, Waterworth, Boehnke, Deloukas, Groop, Hunter, Thorsteinsdottir, Schlessinger, Wichmann, Frayling, Abecasis, Hirschhorn, Loos, Stefansson, Mohlke, Barroso and McCarthy2009; Scherag et al. Reference Scherag, Dina, Hinney, Vatin, Scherag, Vogel, Muller, Grallert, Wichmann, Balkau, Heude, Jarvelin, Hartikainen, Levy-Marchal, Weill, Delplanque, Korner, Kiess, Kovacs, Rayner, Prokopenko, McCarthy, Schafer, Jarick, Boeing, Fisher, Reinehr, Heinrich, Rzehak, Berdel, Borte, Biebermann, Krude, Rosskopf, Rimmbach, Rief, Fromme, Klingenspor, Schurmann, Schulz, Nothen, Muhleisen, Erbel, Jockel, Moebus, Boes, Illig, Froguel, Hebebrand and Meyre2010; Dorajoo et al. Reference Dorajoo, Blakemore, Sim, Ong, Ng, Seielstad, Wong, Saw, Froguel, Liu and Tai2012), which has been confirmed in some (Bille et al. Reference Bille, Banasik, Justesen, Sandholt, Sandbaek, Lauritzen, Jorgensen, Witte, Holm, Hansen and Pedersen2011; Albuquerque et al. Reference Albuquerque, Nobrega, Rodriguez-Lopez and Manco2014; Krishnan et al. Reference Krishnan, Thompson, Mitchell, Murphy, McCowan and Shelling2017), but not all (Gonzalez et al. Reference Gonzalez, Estevez, Giralt, Caceres, Perez, Gonzalez-Carpio, Ballester, Sunyer and Rodriguez-Lopez2014; Volckmar et al. Reference Volckmar, Han, Putter, Haas, Vogel, Knoll, Struve, Gobel, Haas, Herrfurth, Jarick, Grallert, Schurmann, Al-Hasani, Hebebrand, Sauer and Hinney2016; Hotta et al. Reference Hotta, Nakamura, Nakamura, Matsuo, Nakata, Kamohara, Miyatake, Kotani, Komatsu, Itoh, Mineo, Wada, Yoneda, Nakajima, Funahashi, Miyazaki, Tokunaga, Kawamoto, Masuzaki, Ueno, Hamaguchi, Tanaka, Yamada, Hanafusa, Oikawa, Yoshimatsu, Nakao, Sakata, Matsuzawa, Nakamura and Kamatani2010) follow-up studies.

There is, therefore, a body of solid evidence supporting a significant role of the MSRA gene in personality traits, psychiatric disorders, and the regulation of BMI; however, its relation to ED remains unexplored. In the present work, we aimed to address this research gap by examining whether the variability in the MSRA gene locus may be associated with ED-related and general psychopathological symptoms that are commonly found in these patients. In addition, by including a group of control subjects, we examined the putative influence of this variability on AN risk.

Patients and methods

Subjects

The patient group consisted of 233 consecutive, Caucasian female patients with AN who were referred to the Eating Disorders Unit (Institute of Mental Disorders, Badajoz, Spain) by their General Practitioner because of symptoms indicative of AN. Patients were interviewed and diagnosed, according to Diagnostic and Statistical Manual of Mental Disorders fifth edition (DSM-5) guidelines, by collaborating clinicians who were blind to genotype. Exclusion criteria included intellectual disability, dementia, schizophrenia, Turner’s syndrome, other neurological disorders, and endocrine pathologies. All patients or their legal guardians gave written consent for their participation in the study, which had been approved by the Bioethics Committee of the University of Extremadura (March 6, 2018), and were carried out in accordance with the Declaration of Helsinki and its subsequent revisions.

The control group consisted of 369 anonymous, female Spanish donors with normal BMI and no records of psychiatric or endocrine disorders. Their genetic material was obtained from the Carlos III DNA National Bank (University of Salamanca, Salamanca, Spain).

Psychometric evaluation

To evaluate ED-related and general psychopathological symptoms, the patients completed the Eating Disorders Inventory Test-2 (EDI-2) and the Symptom Checklist 90 Revised (SCL-90R) self-reported questionnaires, respectively.

The EDI-2 questionnaire gives information about 11 items, namely, Drive for Thinness, Bulimia, Body Dissatisfaction, Ineffectiveness, Perfectionism, Interpersonal Distrust, Interoceptive Awareness and Maturity Fears, Asceticism, Impulse Regulation, and Social Insecurity. This test has been validated in the Spanish population with high internal consistency between the different traits examined (Guimera & Torrubia Reference Guimera and Torrubia1987). SCL-90R, which has also been validated in Spaniards with good results (Derogaitis Reference Derogaitis2002), provides scores obtained for Somatisation, Obsessive Compulsive, Interpersonal Sensitivity, Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation, Psychoticism, and Additional Items. These scores are summarised in three indexes, namely, Global Severity Index (GSI), Positive Symptom Distress Index (PSDI), and Positive Symptom Total (PST).

Genetic analyses

A 10-ml blood sample was drawn from each patient at the time of their first visit to the ED unit and stored at −80ºC until DNA purification, which was performed with a standard phenol–chloroform extraction method. The coding and adjacent regions of the MSRA gene (ENSG00000175806, HGNC:7377) were retrieved using the GRCh38.p13 genome assembly and tag-SNPs (single-nucleotide polymorphisms that are representative of a certain haplotype) were assigned by Haploview 4.2, setting the minor allele frequency threshold at 10% and the pairwise tagging with a minimum r-square of 0.80. With these conditions, 14 tag-SNPs were identified with minor allele frequencies ranging from 0.129 to 0.491 (Table 1 and Supplementary Figure S1).

Table 1.

Tag-SNPs identified in the region encompassing the MSRA gene

HW, Hardy–Weinberg equilibrium; MAF, minor allele frequency; SNP, single-nucleotide polymorphism.

Genotype analyses were carried out by a MassArray system (Agena Bioscience) with iPlex Gold technology at the Spanish Genotyping National Centre (CEGEN-ISCIII, Santiago de Compostela, Spain).

Statistical analyses

Quantitative variables, e.g. psychometric scores, are shown as mean ± standard deviation (SD) values and were compared with the Student’s T/Mann–Whitney or ANOVA/Kruskal–Wallis tests, depending on the normality of the data and the number of groups analyzed. Categorical variables were compared by the Chi-square test and odds ratios (OR) with 95% confidence intervals (CI) were obtained. The assessment of risk associations with SNPs was performed by logistic regression models adjusted for age using the SNPassoc package in the R environment (https://cran.r-project.org/web/packages/SNPassoc/index.html). The same software was used to detect age-adjusted associations between genotypes and quantitative variables by linear regression. With the aim of identifying regions in the MSRA gene locus whose variability might have relevant consequences, we run association analyses with consecutive 3-SNP haplotypes (sliding-window approach) using PLINK v1.07 (Purcell et al. Reference Purcell, Neale, Todd-Brown, Thomas, Ferreira, Bender, Maller, Sklar, de Bakker, Daly and Sham2007) with a haplotype frequency cutoff of 0.1.

After testing all inheritance models in the preliminary genetic analyses, we decided to utilise the dominant model for all the variants considered, because the resulting genotype groups were the more balanced in terms of size and because resulted in far more significant associations.

The statistical power calculation was carried out with Quanto software v. 1.2.4 (University of Southern California) by testing minor allele frequencies with a type-I error of 0.05. With the available sample size, the statistical power to detect differences in the psychometric scores ranged from 0.870 to 0.945, depending on the minor allele frequencies. P values were adjusted for multiple testing by the Benjamini–Hochberg False Discovery Rate (FDR) method, considering 14 markers in the single-marker study and 12 combinations in the haplotype analysis.

Results

Patients with AN had significantly lower BMI (17.32 ± 2.07 vs. 23.39 ± 2.72), weight (44.97 ± 6.86 vs. 63.11 ± 7.68 kg), and height (1.61 ± 0.07 vs.1.64 ± 0.06 m) than healthy females. Mean ± standard deviation global psychometric scores obtained by the AN patients were EDI-2:89.37 ± 46.48, GSI: 1.56 ± 0.81, PST: 61.19 ± 21.57, and PSDI: 2.18 ± 0.59.

Patients with the restrictive (p = 159) or binge–purge (p = 74) anorexia subtypes did not show statistically significant differences in the scores obtained in the psychometric evaluation (Supplementary Table S1), and hence, the AN patients were treated as a whole group in the subsequent analyses.

Associations between single markers with ED-related psychopathology

Figure 1(A) depicts the impact of MSRA tag-SNPs on the psychometric evaluation. Two polymorphisms, rs11249969 and rs814422, which were in relative LD (D’ = 0.95, r2 = 0.41), had a remarkable effect on the global score obtained by the AN patients in the psychopathology measured by the EDI-2 test. Thus, carriers of the wild-type rs11249969 GG and rs814422 CC genotypes obtained significantly higher EDI-2 scores than patients with variant alleles in these two loci. Mean (and standard error values) were 100.57 (4.68) vs. 81.84 (4.14), adjusted p value for multiple testing (FDR-q) = 0.020 for rs11249969, and 98.69 (4.00) vs. 76.22 (4.77), FDR-q = 0.040 for rs814422. The wild-type rs814422 CC genotype was also found to be related to higher scores in Ineffectiveness (FDR-q = 0.020) and Interpersonal Distrust [FDR-q = 0.040, Fig. 1(A)].

Fig. 1.

Overview of the effect of MSRA tag-SNPs on the scores obtained by the Anorexia Nervosa patients in (A) the EDI-2 and (B) SCL-90R inventories. Light color represents a significant association (p < 0.05). Dark color represents a significant association after correction for multiple testing (FDR-q < 0.05). DT, Drive for thinness; B, Bulimia; BD, Body dissatisfaction; I, Inefficacy; P, Perfectionism; ID, Interpersonal Distrust; IA, Interoceptive awareness; MF, Maturity fears; A, Asceticism; IR, Impulse regulation; SI, Social insecurity; GSI, Global severity index; PST, Positive symptom; PSDI, Positive symptom distress index; SOM, Somatization; OC, Obsessive–compulsive; ANX, Anxiety; DEPR, Depression; SENS, Sensitivity; HOST, Hostility; PhANX, Phobic anxiety; PARId, Paranoid ideation; PSYCH, Psychotism; ADD, additional items.

Associations between single markers with general psychopathology

General psychopathological symptoms were assessed by the SCL-90R inventory. Three consecutive tag-SNPs, namely, rs11249969, rs814422, and rs69886911 (spanning positions 10074468 to 10121013 in the MSRA gene), were observed to significantly affect the results after correcting for multiple testing [Fig. 1(B)]. The first two SNPs had already been shown to affect EDI-2 results. The effect of the rs814422 SNP was specially marked, as carriers of the CC genotype scored higher than women with the CC/TT genotypes in all three general indices and the ten individual scales (Table 2). The effect of the rs11249969 SNP was also highly relevant as the wild-type GG genotype increased the scores of all the items, with statistically significant results in eight out of the 13 scales (Table 3). Finally, in comparison with carriers of variant alleles, those patients harbouring the rs6986911 GG wild-type genotype also scored higher in Sensitivity [2.02 (0.11) vs. 1.64 (0.08), FDR-q = 0.037] and Hostility [1.84 (0.14) vs. 1.38 (0.08), FDR-q = 0.018].

Table 2.

Influence of rs814422 on EDI-2 and SCL-90R scores obtained by the patients. Mean values ± standard deviation are shown. Significant values after correction for multiple testing are shown in boldface type

A, Asceticism; ADD, additional items; ANX, Anxiety; B, Bulimia; BD, Body dissatisfaction; DEPR, Depression; DT, Drive for thinness; GSI, Global severity index; HOST, Hostility; I, Inefficacy; IA, Interoceptive awareness; ID, Interpersonal Distrust; IR, Impulse regulation; MF, Maturity fears; OC, Obsessive–compulsive; P, Perfectionism; PARId, Paranoid ideation; PhANX, Phobic anxiety; PSDI, Positive symptom distress index; PST, Positive symptom; PSYCH, Psychotism; SENS, Sensitivity; SI, Social insecurity; SOM, Somatization.

Table 3.

Influence of rs11249969 on EDI-2 and SCL-90R scores obtained by the patients. Mean values ± standard deviation are shown. Significant values after correction for multiple testing are shown in boldface type

A, Asceticism; ADD, additional items; ANX, Anxiety; B, Bulimia; BD, Body dissatisfaction; DEPR, Depression; DT, Drive for thinness; GSI, Global severity index; HOST, Hostility; I, Inefficacy; IA, Interoceptive awareness; ID, Interpersonal Distrust; IR, Impulse regulation; MF, Maturity fears; OC, Obsessive–compulsive; P, Perfectionism; PARId, Paranoid ideation; PSDI, Positive symptom distress index; PST, Positive symptom; SENS, Sensitivity; SI, Social insecurity; SOM, Somatization; PhANX, Phobic anxiety; PSYCH, Psychotism.

Sliding-window analysis

We performed a sliding-window analysis by grouping the variants into 3-SNP adjacent haplotypes and analyzing their influence on the psychometric scores. With regard to the psychopathology measured by the EDI-2 inventory, the results mirrored the results of the single-marker analysis, as the global score was the parameter showing the strongest associations, with the five first haplotypes displaying FDR-q values lower than 0.05 (Fig. 2). Furthermore, in addition to the associations with Ineffectiveness and Interpersonal distrust observed in the single-marker study, several more traits, namely, Drive for thinness, Maturity fears, Asceticism, Bulimia, and Perfectionism, also showed significant associations with at least one haplotype (Fig. 2).

Fig. 2.

Summary of the sliding-window analysis for the association of 3-SNP MSRA haplotypes with the scores obtained by the Anorexia Nervosa patients on eating disorders-related psychopathology measured by the EDI-2 inventory. The dotted line represents the 0.05 adjusted q-level of significance. DT, Drive for thinness; B, Bulimia; BD, Body dissatisfaction; I, Inefficacy; P, Perfectionism; ID, Interpersonal Distrust; IA, Interoceptive awareness; MF, Maturity fears; A, Asceticism; IR, Impulse regulation; SI, Social insecurity.

The magnitude of the associations with the SCL-90R results was far greater than that resulting from the EDI-2 scores. The symptom that showed the greatest association with the MSRA haplotypes was Depression, which displayed FDR-q values of 1.03E-04 and 3.60E-06 for haplotypes rs11249969/rs814422/rs6986911 and rs6986911/rs17746245/rs1484645, respectively. In any case, all the SCL-90R scales were significantly associated with at least one but often several haplotypes (Fig. 3).

Fig. 3.

Summary of the sliding-window analysis for the association of 3-SNP MSRA haplotypes with the scores obtained by the Anorexia Nervosa patients on general psychopathology measured by the SCL-90R inventory. The dotted line represents the 0.05 adjusted q-level of significance. GSI, Global severity index; PST, Positive symptom; PSDI, Positive symptom distress index; SOM, Somatization; OC, Obsessive–compulsive; ANX, Anxiety; DEPR, Depression; SENS, Sensitivity; HOST, Hostility; PhANX, Phobic anxiety; PARId, Paranoid ideation; PSYCH, Psychotism; ADD, additional items.

In general, variability in a proximal region of the MSRA gene (greyed area) spanning 187.8 Kbp (positions 10061976 to 10249860) was observed to profoundly affect the scores of several scales of the EDI-2 inventory and virtually all of the scales measured by the SCL-90R test (greyed area in Figs. 2 and 3).

Non-psychometric analyses

In contrast to the results obtained in the genetic association analyses with the psychometric scores, there were no significant results regarding the impact of MSRA tag-SNPs on anthropometric parameters, neither in patients nor in controls. Only the rs6601450 GG genotype was found to be associated with higher BMI values (17.81 ± 0.23 vs. 17.13 ± 0.17 for GT/TT genotypes, p = 0.023) in the AN group, but the association lost statistical significance after correcting for multiple comparisons. A summary of the results of the genetic association analyses with BMI, weight, and height in both patients and controls is shown in Supplementary Table S2.

Finally, risk analyses adjusted for age showed that none of the MSRA tag-SNPs or haplotypes analyzed and affected the susceptibility to AN. Odds ratio and p values for all the tag-SNPs studied are depicted in Supplementary Table S3.

Availability of data and materials: The data that support the findings of this study are openly available at Figshare, with DOI: 10.6084/m9.figshare.13621901.

Discussion

We have previously reported that variability in several genes of the central nervous system may contribute to various psychopathological comorbidities in ED (Gamero-Villarroel et al. Reference Gamero-Villarroel, Gordillo, Carrillo, Garcia-Herraiz, Flores, Jimenez, Monge, Rodriguez-Lopez and Gervasini2014; Gamero-Villarroel et al. Reference Gamero-Villarroel, Gonzalez, Gordillo, Carrillo, Garcia-Herraiz, Flores, Rodriguez-Lopez and Gervasini2015; Gervasini and Gamero-Villarroel Reference Gervasini and Gamero-Villarroel2015; Gamero-Villarroel et al. Reference Gamero-Villarroel, Gonzalez, Rodriguez-Lopez, Albuquerque, Carrillo, Garcia-Herraiz, Flores and Gervasini2017; Gervasini et al. Reference Gervasini, Gonzalez, Gamero-Villarroel, Mota-Zamorano, Carrillo, Flores and Garcia-Herraiz2018). These comorbid disorders are very frequent among AN patients and often constitute an unfavourable prognostic characteristic in this ED. Therefore, the systematic evaluation of psychopathology in these patients and the study of the factors behind these symptoms, e.g. genetics, are very important for understanding AN pathogenesis and the implementation of efficient therapies (Salbach-Andrae et al. Reference Salbach-Andrae, Lenz, Simmendinger, Klinkowski, Lehmkuhl and Pfeiffer2008).

Our results show that two tag-SNPs in the MSRA gene, rs11249969 and rs814422, significantly modified the global results obtained by the AN patients in the EDI-2 inventory, which measures ED-related psychopathology. There are not many examples in the literature of studies analyzing the influence of genetics on psychopathological symptoms in AN. Some reports have focused on the influence of dopaminergic and serotonergic genes (Rybakowski et al. Reference Rybakowski, Slopien, Dmitrzak-Weglarz, Czerski, Rajewski and Hauser2006; Bachner-Melman et al. Reference Bachner-Melman, Lerer, Zohar, Kremer, Elizur, Nemanov, Golan, Blank, Gritsenko and Ebstein2007; Steiger et al. Reference Steiger, Richardson, Schmitz, Joober, Israel, Bruce, Gauvin, Dandurand and Anestin2009; Gonzalez et al. Reference Gonzalez, Mota-Zamorano, Garcia-Herraiz, Lopez-Nevado and Gervasini2021), whilst others have looked into hypothalamic genes, such as BDNF, TFAP2B, or KCTD15 (Rybakowski et al. Reference Rybakowski, Dmitrzak-Weglarz, Szczepankiewicz, Skibinska, Slopien, Rajewski and Hauser2007; Gervasini & Gamero-Villarroel Reference Gervasini and Gamero-Villarroel2015; Gamero-Villarroel et al. Reference Gamero-Villarroel, Gonzalez, Rodriguez-Lopez, Albuquerque, Carrillo, Garcia-Herraiz, Flores and Gervasini2017). One GWAS aimed to discover associations with ED-related symptoms, behaviours, and traits also found several variants that showed suggestive evidence for association (Boraska et al. Reference Boraska, Davis, Cherkas, Helder, Harris, Krug, Liao, Treasure, Ntalla, Karhunen, Keski-Rahkonen, Christakopoulou, Raevuori, Shin, Dedoussis, Kaprio, Soranzo, Spector, Collier and Zeggini2012). To the best of our knowledge, there are no previous studies on the involvement of MSRA in ED, let alone studies dealing with associated psychopathology. There are, however, some examples in the general population that reveal associations between MSRA and symptoms that are relevant in ED. For example, several GWAS have identified MSRA variants solidly associated with irritability (Day et al. Reference Day, Helgason, Chasman, Rose, Loh, Scott, Helgason, Kong, Masson, Magnusson, Gudbjartsson, Thorsteinsdottir, Buring, Ridker, Sulem, Stefansson, Ong and Perry2016) and neuroticism (Okbay et al. Reference Okbay, Baselmans, De Neve, Turley, Nivard, Fontana, Meddens, Linner, Rietveld, Derringer, Gratten, Lee, Liu, de Vlaming, Ahluwalia, Buchwald, Cavadino, Frazier-Wood, Furlotte, Garfield, Geisel, Gonzalez, Haitjema, Karlsson, van der Laan, Ladwig, Lahti, van der Lee, Lind, Liu, Matteson, Mihailov, Miller, Minica, Nolte, Mook-Kanamori, van der Most, Oldmeadow, Qian, Raitakari, Rawal, Realo, Rueedi, Schmidt, Smith, Stergiakouli, Tanaka, Taylor, Thorleifsson, Wedenoja, Wellmann, Westra, Willems, Zhao, Amin, Bakshi, Bergmann, Bjornsdottir, Boyle, Cherney, Cox, Davies, Davis, Ding, Direk, Eibich, Emeny, Fatemifar, Faul, Ferrucci, Forstner, Gieger, Gupta, Harris, Harris, Holliday, Hottenga, De Jager, Kaakinen, Kajantie, Karhunen, Kolcic, Kumari, Launer, Franke, Li-Gao, Liewald, Koini, Loukola, Marques-Vidal, Montgomery, Mosing, Paternoster, Pattie, Petrovic, Pulkki-Raback, Quaye, Raikkonen, Rudan, Scott, Smith, Sutin, Trzaskowski, Vinkhuyzen, Yu, Zabaneh, Attia, Bennett, Berger, Bertram, Boomsma, Snieder, Chang, Cucca, Deary, van Duijn, Eriksson, Bultmann, de Geus, Groenen, Gudnason, Hansen, Hartman, Haworth, Hayward, Heath, Hinds, Hypponen, Iacono, Jarvelin, Jockel, Kaprio, Kardia, Keltikangas-Jarvinen, Kraft, Kubzansky, Lehtimaki, Magnusson, Martin, McGue, Metspalu, Mills, de Mutsert, Oldehinkel, Pasterkamp, Pedersen, Plomin, Polasek, Power, Rich, Rosendaal, den Ruijter, Schlessinger, Schmidt, Svento, Schmidt, Alizadeh, Sorensen, Spector, Starr, Stefansson, Steptoe, Terracciano, Thorsteinsdottir, Thurik, Timpson, Tiemeier, Uitterlinden, Vollenweider, Wagner, Weir, Yang, Conley, Smith, Hofman, Johannesson, Laibson, Medland, Meyer, Pickrell, Esko, Krueger, Beauchamp, Koellinger, Benjamin, Bartels and Cesarini2016; Luciano et al. Reference Luciano, Hagenaars, Davies, Hill, Clarke, Shirali, Harris, Marioni, Liewald, Fawns-Ritchie, Adams, Howard, Lewis, Gale, McIntosh and Deary2018; Chu et al. Reference Chu, Liu, Wen, Li, Cheng, Cheng, Zhang, Mei, Qi, Liang, Ye, Kafle, Wu, Wang, Wang, Ning and Zhang2020). Moreover, a replication study analyzing 16 features in over 140 000 participants also demonstrated significant effects of MSRA variants on neuroticism and extraversion (Boutwell et al. Reference Boutwell, Hinds, Tielbeek, Ong, Day and Perry2017). The findings presented herein show that, aside from the impact on the global EDI-2 scores, and after correction for multiple testing, rs814422 was still significantly associated with Ineffectiveness, which assesses feelings of inadequacy, insecurity and worthlessness, and Interpersonal Distrust. Again, there are no previous data linking MSRA with ED-related psychological comorbidities, but a number of studies in the ED setting have reported these two psychological features being modulated by other genes expressed in the brain (Kamakura et al. Reference Kamakura, Ando, Ono and Maekawa2003; Nisoli et al. Reference Nisoli, Brunani, Borgomainerio, Tonello, Dioni, Briscini, Redaelli, Molinari, Cavagnini and Carruba2007; Gonzalez et al. Reference Gonzalez, Mota-Zamorano, Garcia-Herraiz, Lopez-Nevado and Gervasini2021). The effect on Ineffectiveness in particular has been suggested to account for the initial stimulus to take up dieting behaviour, which could evolve to AN should other pathological traits be present (Nisoli et al. Reference Nisoli, Brunani, Borgomainerio, Tonello, Dioni, Briscini, Redaelli, Molinari, Cavagnini and Carruba2007).

The most relevant findings in this work have to do with the general psychopathology assessed by the SCL-90R inventory. It is true that causality has not unequivocally been established yet, but psychiatric comorbidities can be as high as 80% in AN (Hudson et al. Reference Hudson, Hiripi, Pope and Kessler2007; Jaite et al. Reference Jaite, Hoffmann, Glaeske and Bachmann2013; Meczekalski et al. Reference Meczekalski, Podfigurna-Stopa and Katulski2013), with anxiety and depression being the most commonly reported disorders (Preti et al. Reference Preti, Girolamo, Vilagut, Alonso, Graaf, Bruffaerts, Demyttenaere, Pinto-Meza, Haro and Morosini2009; Jaite et al. Reference Jaite, Hoffmann, Glaeske and Bachmann2013). In our population of AN patients, rs11249969 and rs814422, which, interestingly enough, were the same SNPs that modified the EDI-2 results, displayed a profound effect on the scores obtained by the patients in the SCL-90R questionnaire. Most remarkably, the rs814422 CC genotype increased the scores of all the items with statistical significance after correcting for multiple testing. Affected symptoms included, for instance, Depression, a comorbidity with predictive value of AN outcome (Eskild-Jensen et al. Reference Eskild-Jensen, Stoving, Flindt and Sjogren2020; Kahn et al. Reference Kahn, Brunstein-Klomek, Hadas, Snir and Fennig2020); Anxiety, whose prevalence is markedly higher in AN patients as compared to control subjects (Swinbourne & Touyz Reference Swinbourne and Touyz2007; Lloyd et al. Reference Lloyd, Sallis, Verplanken, Haase and Munafo2020); or obsessive–compulsive, a disorder with a considerable overlap with AN that may reflect common psychological, neurobiological, or genetic factors (Serpell et al. Reference Serpell, Livingstone, Neiderman and Lask2002; Yilmaz et al. Reference Yilmaz, Halvorsen, Bryois, Yu, Thornton, Zerwas, Micali, Moessner, Burton, Zai, Erdman, Kas, Arnold, Davis, Knowles, Breen, Scharf, Nestadt, Mathews, Bulik, Mattheisen and Crowley2020). Finally, we should not rule out the possibility that, being rs11249969 and rs814422 in relative linkage disequilibrium (LD), the observed associations might in fact reflect the influence of a single major haplotype.

The sliding-window study confirmed that the results obtained in the single-marker analysis and showed that the variability of a proximal region of the gene was able to markedly modify the psychometric scores obtained by the AN patients. Of special interest were the associations with the symptoms measured by SCL-90R, particularly with depression, which showed two highly significant hits with MSRA haplotypes. This finding is in the same line as those by Chu et al., who recently published a GWAS reporting several MSRA variants related to depressive symptoms in the general population (Chu et al. Reference Chu, Liu, Wen, Li, Cheng, Cheng, Zhang, Mei, Qi, Liang, Ye, Kafle, Wu, Wang, Wang, Ning and Zhang2020). In this regard, the increase of reactive oxygen species (ROS) in the brain has been solidly connected with depression (Bhatt et al. Reference Bhatt, Nagappa and Patil2020). A disruption of MsrA enzyme function, which is part of the antioxidant defence system in the brain (Reiterer et al. Reference Reiterer, Schmidt-Kastner and Milton2019), might, therefore, contribute, at least in part, to the disorder. Indeed, this decreased function has been associated with a variety of psychiatric disorders (Jiang & Moskovitz Reference Jiang and Moskovitz2018). It should be mentioned, though, that the tag-SNPs analyzed in this study were all intronic, hence with no likely relevant consequences for enzyme activity. Their value lies on their role as representative markers of a region in high LD in which relevant mutations must be located.

Finally, we could not find a significant effect of any of the MSRA variants or haplotypes on the anthropometric parameters of AN patients or healthy females. This is in agreement with former studies (Hotta et al. Reference Hotta, Nakamura, Nakamura, Matsuo, Nakata, Kamohara, Miyatake, Kotani, Komatsu, Itoh, Mineo, Wada, Yoneda, Nakajima, Funahashi, Miyazaki, Tokunaga, Kawamoto, Masuzaki, Ueno, Hamaguchi, Tanaka, Yamada, Hanafusa, Oikawa, Yoshimatsu, Nakao, Sakata, Matsuzawa, Nakamura and Kamatani2010; Gonzalez et al. Reference Gonzalez, Estevez, Giralt, Caceres, Perez, Gonzalez-Carpio, Ballester, Sunyer and Rodriguez-Lopez2014; Volckmar et al. Reference Volckmar, Han, Putter, Haas, Vogel, Knoll, Struve, Gobel, Haas, Herrfurth, Jarick, Grallert, Schurmann, Al-Hasani, Hebebrand, Sauer and Hinney2016) that could not replicate the alleged MSRA-BMI connection described in some GWAS (Lindgren et al. Reference Lindgren, Heid, Randall, Lamina, Steinthorsdottir, Qi, Speliotes, Thorleifsson, Willer, Herrera, Jackson, Lim, Scheet, Soranzo, Amin, Aulchenko, Chambers, Drong, Luan, Lyon, Rivadeneira, Sanna, Timpson, Zillikens, Zhao, Almgren, Bandinelli, Bennett, Bergman, Bonnycastle, Bumpstead, Chanock, Cherkas, Chines, Coin, Cooper, Crawford, Doering, Dominiczak, Doney, Ebrahim, Elliott, Erdos, Estrada, Ferrucci, Fischer, Forouhi, Gieger, Grallert, Groves, Grundy, Guiducci, Hadley, Hamsten, Havulinna, Hofman, Holle, Holloway, Illig, Isomaa, Jacobs, Jameson, Jousilahti, Karpe, Kuusisto, Laitinen, Lathrop, Lawlor, Mangino, McArdle, Meitinger, Morken, Morris, Munroe, Narisu, Nordstrom, Nordstrom, Oostra, Palmer, Payne, Peden, Prokopenko, Renstrom, Ruokonen, Salomaa, Sandhu, Scott, Scuteri, Silander, Song, Yuan, Stringham, Swift, Tuomi, Uda, Vollenweider, Waeber, Wallace, Walters, Weedon, Witteman, Zhang, Zhang, Caulfield, Collins, Davey Smith, Day, Franks, Hattersley, Hu, Jarvelin, Kong, Kooner, Laakso, Lakatta, Mooser, Morris, Peltonen, Samani, Spector, Strachan, Tanaka, Tuomilehto, Uitterlinden, van Duijn, Wareham, Hugh, Waterworth, Boehnke, Deloukas, Groop, Hunter, Thorsteinsdottir, Schlessinger, Wichmann, Frayling, Abecasis, Hirschhorn, Loos, Stefansson, Mohlke, Barroso and McCarthy2009; Scherag et al. Reference Scherag, Dina, Hinney, Vatin, Scherag, Vogel, Muller, Grallert, Wichmann, Balkau, Heude, Jarvelin, Hartikainen, Levy-Marchal, Weill, Delplanque, Korner, Kiess, Kovacs, Rayner, Prokopenko, McCarthy, Schafer, Jarick, Boeing, Fisher, Reinehr, Heinrich, Rzehak, Berdel, Borte, Biebermann, Krude, Rosskopf, Rimmbach, Rief, Fromme, Klingenspor, Schurmann, Schulz, Nothen, Muhleisen, Erbel, Jockel, Moebus, Boes, Illig, Froguel, Hebebrand and Meyre2010; Dorajoo et al. Reference Dorajoo, Blakemore, Sim, Ong, Ng, Seielstad, Wong, Saw, Froguel, Liu and Tai2012). In this regard, Scherag et al. showed that at least two of these MSRA loci identified as BMI regulators in adolescents were in fact located between the MSRA and the TNKS gene (Scherag et al. Reference Scherag, Dina, Hinney, Vatin, Scherag, Vogel, Muller, Grallert, Wichmann, Balkau, Heude, Jarvelin, Hartikainen, Levy-Marchal, Weill, Delplanque, Korner, Kiess, Kovacs, Rayner, Prokopenko, McCarthy, Schafer, Jarick, Boeing, Fisher, Reinehr, Heinrich, Rzehak, Berdel, Borte, Biebermann, Krude, Rosskopf, Rimmbach, Rief, Fromme, Klingenspor, Schurmann, Schulz, Nothen, Muhleisen, Erbel, Jockel, Moebus, Boes, Illig, Froguel, Hebebrand and Meyre2010). It could, therefore, be that the association with BMI was more related to TNKS; in this case, our study, focused on MSRA tag-SNPs, would have been unable to detect it.

In the same manner, we could not identify any MSRA variant or haplotype associated with the risk for AN. In our former association studies carried on in the ED setting, we have persistently observed how genetic variability in obesity-related central genes has a negligible-to-weak effect on the risk for the disorder. In contrast, we could generally confirm a remarkable impact on the psychopathology displayed by the patients (Gamero-Villarroel et al. Reference Gamero-Villarroel, Gordillo, Carrillo, Garcia-Herraiz, Flores, Jimenez, Monge, Rodriguez-Lopez and Gervasini2014; Gamero-Villarroel et al. Reference Gamero-Villarroel, Gonzalez, Gordillo, Carrillo, Garcia-Herraiz, Flores, Rodriguez-Lopez and Gervasini2015; Gamero-Villarroel et al. Reference Gamero-Villarroel, Gonzalez, Rodriguez-Lopez, Albuquerque, Carrillo, Garcia-Herraiz, Flores and Gervasini2017). This may suggest that the affected symptoms are likely more important in terms of the severity or persistence of the ED than in terms of susceptibility, where environmental or socio-cultural factors might play a more relevant role (Gervasini & Gamero-Villarroel Reference Gervasini and Gamero-Villarroel2015).

This study has some limitations. First, the sample size generated adequate statistical power to detect differences in the psychometric scores, but the inclusion of more subjects would have been desirable in the case–control analysis to unequivocally rule out an impact on AN risk. Second, the age of the control subjects was significantly higher than that of the AN patients. This obviously did not affect the genetic analyses, but could have partly contributed to the differences in the anthropological parameters reported for the two study groups. Finally, the DNA samples of the control subjects were obtained from an anonymous DNA bank; therefore, psychometric scores were not available for this group. Whilst the main goal of the study, i.e. the assessment of the association of MSRA genetic variability with psychopathology in AN, remained unaltered, having access to these data would have provided with additional, interesting information on the psychological differences between AN patients and healthy women.

This study adds up to the growing evidence that points to genetics as a key factor in the onset or maintenance of psychopathology in ED patients. It is crucial to improve our understanding of these symptoms in AN, as it will help identify at-risk individuals, adopt prevention-oriented solutions and individualise therapies focusing on key elements underlying the ED (Dufresne et al. Reference Dufresne, Bussieres, Bedard, Gingras, Blanchette-Sarrasin and Begin2020). In this work, we have shown, for the first time to the best of our knowledge, that variability in the MSRA gene locus is associated with changes in the psychometric scores of AN patients. In particular, psychological symptoms such as depression are specially affected. A proximal region of the gene seems to be the locus more intimately related to these changes.

Supplementary material

To view supplementary material for this article, please visit https://doi.org/10.1017/neu.2021.24

Acknowledgements

We would like to thank the DNA repository of the Instituto de Salud Carlos III (www.bancoadn.org) for providing with genetic material from healthy individuals and the members of the Centro Nacional de Genotipado-Instituto de Salud Carlos III (CEGen; www.cegen.org) for their technical assistance.

Authors’ contributions

Guillermo Gervasini designed the study, material preparation was carried out by David Albuquerque and Sonia Mota-Zamorano, data collection was performed by Isalud Flores and Angustias García-Herráiz, and analyses were performed by Luz M González and Guillermo Gervasini. The first draft of the manuscript was written by Guillermo Gervasini, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Financial support

This work has been supported in part by a grant from the Alicia Koplowitz Foundation and by grant GR18007 from Junta de Extremadura, Mérida (Spain) and Fondo Europeo de Desarrollo Regional (FEDER) “Una manera de hacer Europa”. The sponsors did not have any role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.

Conflict of interest

None.

Ethical standard

The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008.

References

Albuquerque, D, Nobrega, C, Rodriguez-Lopez, R and Manco, L (2014) Association study of common polymorphisms in MSRA, TFAP2B, MC4R, NRXN3, PPARGC1A, TMEM18, SEC16B, HOXB5 and OLFM4 genes with obesity-related traits among Portuguese children. Journal of Human Genetics 59, 307–313.CrossRefGoogle ScholarPubMed
Amare, AT, Schubert, KO, Tekola-Ayele, F, Hsu, YH, Sangkuhl, K, Jenkins, G, Whaley, RM, Barman, P, Batzler, A, Altman, RB, Arolt, V, Brockmoller, J, Chen, CH, Domschke, K, Hall-Flavin, DK, Hong, CJ, Illi, A, Ji, Y, Kampman, O, Kinoshita, T, Leinonen, E, Liou, YJ, Mushiroda, T, Nonen, S, Skime, MK, Wang, L, Kato, M, Liu, YL, Praphanphoj, V, Stingl, JC, Bobo, WV, Tsai, SJ, Kubo, M, Klein, TE, Weinshilboum, RM, Biernacka, JM and Baune, BT (2018) Association of the polygenic scores for personality traits and response to selective serotonin reuptake inhibitors in patients with major depressive disorder. Front Psychiatry 9, 65.CrossRefGoogle ScholarPubMed
Arcelus, J, Mitchell, AJ, Wales, J and Nielsen, S (2011) Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analysis of 36 studies. Archives of General Psychiatry 68, 724–731.CrossRefGoogle ScholarPubMed
Bachner-Melman, R, Lerer, E, Zohar, AH, Kremer, I, Elizur, Y, Nemanov, L, Golan, M, Blank, S, Gritsenko, I and Ebstein, RP (2007) Anorexia nervosa, perfectionism, and dopamine D4 receptor (DRD4). American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics 144B, 748–756.CrossRefGoogle Scholar
Bhatt, S, Nagappa, AN and Patil, CR (2020) Role of oxidative stress in depression. Drug Discov Today 25, 1270–1276.CrossRefGoogle ScholarPubMed
Bille, DS, Banasik, K, Justesen, JM, Sandholt, CH, Sandbaek, A, Lauritzen, T, Jorgensen, T, Witte, DR, Holm, JC, Hansen, T and Pedersen, O (2011) Implications of central obesity-related variants in LYPLAL1, NRXN3, MSRA, and TFAP2B on quantitative metabolic traits in adult Danes. PLoS One 6, e20640.CrossRefGoogle ScholarPubMed
Boraska, V, Davis, OS, Cherkas, LF, Helder, SG, Harris, J, Krug, I, Liao, TP, Treasure, J, Ntalla, I, Karhunen, L, Keski-Rahkonen, A, Christakopoulou, D, Raevuori, A, Shin, SY, Dedoussis, GV, Kaprio, J, Soranzo, N, Spector, TD, Collier, DA and Zeggini, E (2012) Genome-wide association analysis of eating disorder-related symptoms, behaviors, and personality traits. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics 159B, 803–811.CrossRefGoogle Scholar
Boutwell, B, Hinds, D, Tielbeek, J, Ong, KK, Day, FR and Perry, JRB (2017) Replication and characterization of CADM2 and MSRA genes on human behavior. Heliyon 3, e00349.CrossRefGoogle ScholarPubMed
Bulik, CM, Sullivan, PF, Tozzi, F, Furberg, H, Lichtenstein, P and Pedersen, NL (2006) Prevalence, heritability, and prospective risk factors for anorexia nervosa. Archives of General Psychiatry 63, 305–312.CrossRefGoogle ScholarPubMed
Chu, X, Liu, L, Wen, Y, Li, P, Cheng, B, Cheng, S, Zhang, L, Mei, M, Qi, X, Liang, C, Ye, J, Kafle, OP, Wu, C, Wang, S, Wang, X, Ning, Y and Zhang, F (2020) A genome-wide multiphenotypic association analysis identified common candidate genes for subjective well-being, depressive symptoms and neuroticism. Journal of Psychiatric Research 124, 22–28.CrossRefGoogle ScholarPubMed
Day, FR, Helgason, H, Chasman, DI, Rose, LM, Loh, PR, Scott, RA, Helgason, A, Kong, A, Masson, G, Magnusson, OT, Gudbjartsson, D, Thorsteinsdottir, U, Buring, JE, Ridker, PM, Sulem, P, Stefansson, K, Ong, KK and Perry, JRB (2016) Physical and neurobehavioral determinants of reproductive onset and success. Nature Genetics 48, 617–623.CrossRefGoogle ScholarPubMed
Derogaitis, LR (2002) SCL-90R: Cuestionario de 90 síntomas. Madrid: TEA Ed.Google Scholar
Dorajoo, R, Blakemore, AI, Sim, X, Ong, RT, Ng, DP, Seielstad, M, Wong, TY, Saw, SM, Froguel, P, Liu, J and Tai, ES (2012) Replication of 13 obesity loci among Singaporean Chinese, Malay and Asian-Indian populations. International Journal of Obesity (London) 36, 159–163.CrossRefGoogle ScholarPubMed
Dufresne, L, Bussieres, EL, Bedard, A, Gingras, N, Blanchette-Sarrasin, A and Begin, DC (2020) Personality traits in adolescents with eating disorder: A meta-analytic review. International Journal of Eating Disorders 53, 157–173.CrossRefGoogle ScholarPubMed
Eskild-Jensen, M, Stoving, RK, Flindt, CF and Sjogren, M (2020) Comorbid depression as a negative predictor of weight gain during treatment of anorexia nervosa: a systematic scoping review. European Eating Disorders Review 28, 605–619.CrossRefGoogle ScholarPubMed
Fan, Q, Wang, W, Hao, J, He, A, Wen, Y, Guo, X, Wu, C, Ning, Y, Wang, X, Wang, S and Zhang, F (2017) Integrating genome-wide association study and expression quantitative trait loci data identifies multiple genes and gene set associated with neuroticism. Progress in Neuro-Psychopharmacology and Biological Psychiatry 78, 149–152.CrossRefGoogle ScholarPubMed
Gabbita, SP, Aksenov, MY, Lovell, MA and Markesbery, WR (1999) Decrease in peptide methionine sulfoxide reductase in Alzheimer’s disease brain. Journal of Neurochemistry 73, 1660–1666.CrossRefGoogle ScholarPubMed
Gamero-Villarroel, C, Gonzalez, LM, Gordillo, I, Carrillo, JA, Garcia-Herraiz, A, Flores, I, Rodriguez-Lopez, R and Gervasini, G (2015) Impact of NEGR1 genetic variability on psychological traits of patients with eating disorders. Pharmacogenomics Journal 15, 278–283.CrossRefGoogle ScholarPubMed
Gamero-Villarroel, C, Gonzalez, LM, Rodriguez-Lopez, R, Albuquerque, D, Carrillo, JA, Garcia-Herraiz, A, Flores, I and Gervasini, G (2017) Influence of TFAP2B and KCTD15 genetic variability on personality dimensions in anorexia and bulimia nervosa. Brain and Behavior 7, e00784 CrossRefGoogle ScholarPubMed
Gamero-Villarroel, C, Gordillo, I, Carrillo, JA, Garcia-Herraiz, A, Flores, I, Jimenez, M, Monge, M, Rodriguez-Lopez, R and Gervasini, G (2014) BDNF genetic variability modulates psychopathological symptoms in patients with eating disorders. European Child and Adolescent Psychiatry 23, 669–679.CrossRefGoogle ScholarPubMed
Gervasini, G and Gamero-Villarroel, C (2015) Discussing the putative role of obesity-associated genes in the etiopathogenesis of eating disorders. Pharmacogenomics 16, 1287–1305.CrossRefGoogle ScholarPubMed
Gervasini, G, Gonzalez, LM, Gamero-Villarroel, C, Mota-Zamorano, S, Carrillo, JA, Flores, I and Garcia-Herraiz, A (2018) Effect of dopamine receptor D4 (DRD4) haplotypes on general psychopathology in patients with eating disorders. Gene 654, 43–48.CrossRefGoogle ScholarPubMed
Gonzalez, JR, Estevez, MN, Giralt, PS, Caceres, A, Perez, LM, Gonzalez-Carpio, M, Ballester, F, Sunyer, J and Rodriguez-Lopez, R (2014) Genetic risk profiles for a childhood with severe overweight. Pediatr Obes 9(4), 272–280.CrossRefGoogle ScholarPubMed
Gonzalez, LM, Mota-Zamorano, S, Garcia-Herraiz, A, Lopez-Nevado, E and Gervasini, G (2021) Genetic variants in dopamine pathways affect personality dimensions displayed by patients with eating disorders. Eating and Weight Disorders 26, 93–101.CrossRefGoogle ScholarPubMed
Guimera, E and Torrubia, R (1987) Adaptación española del “Eating Disorder Inventory Inventory” (EDI) en una muestra de pacientes anoréxicas. Anales de Psiquiatría 3, 185–190.Google Scholar
Hotta, K, Nakamura, M, Nakamura, T, Matsuo, T, Nakata, Y, Kamohara, S, Miyatake, N, Kotani, K, Komatsu, R, Itoh, N, Mineo, I, Wada, J, Yoneda, M, Nakajima, A, Funahashi, T, Miyazaki, S, Tokunaga, K, Kawamoto, M, Masuzaki, H, Ueno, T, Hamaguchi, K, Tanaka, K, Yamada, K, Hanafusa, T, Oikawa, S, Yoshimatsu, H, Nakao, K, Sakata, T, Matsuzawa, Y, Nakamura, Y and Kamatani, N (2010) Polymorphisms in NRXN3, TFAP2B, MSRA, LYPLAL1, FTO and MC4R and their effect on visceral fat area in the Japanese population. Journal of Human Genetics 55, 738–742.CrossRefGoogle ScholarPubMed
Hudson, JI, Hiripi, E, Pope, HG Jr and Kessler, RC (2007) The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biological Psychiatry 61, 348–358.CrossRefGoogle ScholarPubMed
Jaite, C, Hoffmann, F, Glaeske, G and Bachmann, CJ (2013) Prevalence, comorbidities and outpatient treatment of anorexia and bulimia nervosa in German children and adolescents. Eating and Weight Disorders 18, 157–165.CrossRefGoogle ScholarPubMed
Jiang, B and Moskovitz, J (2018) The functions of the Mammalian methionine sulfoxide reductase system and related diseases. Antioxidants (Basel) 7, 122.CrossRefGoogle Scholar
Kahn, M, Brunstein-Klomek, A, Hadas, A, Snir, A and Fennig, S (2020) Early changes in depression predict outcomes of inpatient adolescent anorexia nervosa. Eating and Weight Disorders 25, 777–785.CrossRefGoogle ScholarPubMed
Kamakura, T, Ando, J, Ono, Y and Maekawa, H (2003) A twin study of genetic and environmental influences on psychological traits of eating disorders in a Japanese female sample. Twin Research 6, 292–296.CrossRefGoogle Scholar
Kim, HY and Gladyshev, VN (2007) Methionine sulfoxide reductases: selenoprotein forms and roles in antioxidant protein repair in mammals. Biochemical Journal 407, 321–329.CrossRefGoogle ScholarPubMed
Krishnan, M, Thompson, JMD, Mitchell, EA, Murphy, R, McCowan, LME, Shelling, AN, and On Behalf Of The Children Of Scope Study Group, G (2017) Analysis of association of gene variants with obesity traits in New Zealand European children at 6 years of age. Molecular Biosystems 13, 1524–1533.CrossRefGoogle Scholar
Lindgren, CM, Heid, IM, Randall, JC, Lamina, C, Steinthorsdottir, V, Qi, L, Speliotes, EK, Thorleifsson, G, Willer, CJ, Herrera, BM, Jackson, AU, Lim, N, Scheet, P, Soranzo, N, Amin, N, Aulchenko, YS, Chambers, JC, Drong, A, Luan, J, Lyon, HN, Rivadeneira, F, Sanna, S, Timpson, NJ, Zillikens, MC, Zhao, JH, Almgren, P, Bandinelli, S, Bennett, AJ, Bergman, RN, Bonnycastle, LL, Bumpstead, SJ, Chanock, SJ, Cherkas, L, Chines, P, Coin, L, Cooper, C, Crawford, G, Doering, A, Dominiczak, A, Doney, AS, Ebrahim, S, Elliott, P, Erdos, MR, Estrada, K, Ferrucci, L, Fischer, G, Forouhi, NG, Gieger, C, Grallert, H, Groves, CJ, Grundy, S, Guiducci, C, Hadley, D, Hamsten, A, Havulinna, AS, Hofman, A, Holle, R, Holloway, JW, Illig, T, Isomaa, B, Jacobs, LC, Jameson, K, Jousilahti, P, Karpe, F, Kuusisto, J, Laitinen, J, Lathrop, GM, Lawlor, DA, Mangino, M, McArdle, WL, Meitinger, T, Morken, MA, Morris, AP, Munroe, P, Narisu, N, Nordstrom, A, Nordstrom, P, Oostra, BA, Palmer, CN, Payne, F, Peden, JF, Prokopenko, I, Renstrom, F, Ruokonen, A, Salomaa, V, Sandhu, MS, Scott, LJ, Scuteri, A, Silander, K, Song, K, Yuan, X, Stringham, HM, Swift, AJ, Tuomi, T, Uda, M, Vollenweider, P, Waeber, G, Wallace, C, Walters, GB, Weedon, MN, Witteman, JC, Zhang, C, Zhang, W, Caulfield, MJ, Collins, FS, Davey Smith, G, Day, IN, Franks, PW, Hattersley, AT, Hu, FB, Jarvelin, MR, Kong, A, Kooner, JS, Laakso, M, Lakatta, E, Mooser, V, Morris, AD, Peltonen, L, Samani, NJ, Spector, TD, Strachan, DP, Tanaka, T, Tuomilehto, J, Uitterlinden, AG, van Duijn, CM, Wareham, NJ, Hugh, W, Waterworth, DM, Boehnke, M, Deloukas, P, Groop, L, Hunter, DJ, Thorsteinsdottir, U, Schlessinger, D, Wichmann, HE, Frayling, TM, Abecasis, GR, Hirschhorn, JN, Loos, RJ, Stefansson, K, Mohlke, KL, Barroso, I and McCarthy, MI (2009) Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLOS Genetics 5, e1000508.CrossRefGoogle ScholarPubMed
Luciano, M, Hagenaars, SP, Davies, G, Hill, WD, Clarke, TK, Shirali, M, Harris, SE, Marioni, RE, Liewald, DC, Fawns-Ritchie, C, Adams, MJ, Howard, DM, Lewis, CM, Gale, CR, McIntosh, AM and Deary, IJ (2018) Association analysis in over 329,000 individuals identifies 116 independent variants influencing neuroticism. Nature Genetics 50, 6–11.CrossRefGoogle ScholarPubMed
Lloyd, EC, Sallis, HM, Verplanken, B, Haase, AM and Munafo, MR (2020) Understanding the nature of association between anxiety phenotypes and anorexia nervosa: a triangulation approach. BMC Psychiatry 20, 495.CrossRefGoogle ScholarPubMed
Ma, X, Deng, W, Liu, X, Li, M, Chen, Z, He, Z, Wang, Y, Wang, Q, Hu, X, Collier, DA and Li, T (2011) A genome-wide association study for quantitative traits in schizophrenia in China. Genes, Brain and Behavior 10, 734–739.CrossRefGoogle ScholarPubMed
Meczekalski, B, Podfigurna-Stopa, A and Katulski, K (2013) Long-term consequences of anorexia nervosa. Maturitas 75, 215–220.CrossRefGoogle Scholar
Ni, P, Ma, X, Lin, Y, Lao, G, Hao, X, Guan, L, Li, X, Jiang, Z, Liu, Y, Ye, B, Liu, X, Wang, Y, Zhao, L, Cao, L and Li, T (2015) Methionine sulfoxide reductase A (MsrA) associated with bipolar I disorder and executive functions in A Han Chinese population. Journal of Affective Disorders 184, 235–238.CrossRefGoogle Scholar
Nisoli, E, Brunani, A, Borgomainerio, E, Tonello, C, Dioni, L, Briscini, L, Redaelli, G, Molinari, E, Cavagnini, F and Carruba, MO (2007) D2 dopamine receptor (DRD2) gene Taq1A polymorphism and the eating-related psychological traits in eating disorders (anorexia nervosa and bulimia) and obesity. Eating and Weight Disorders 12, 91–96.CrossRefGoogle ScholarPubMed
Okbay, A, Baselmans, BM, De Neve, JE, Turley, P, Nivard, MG, Fontana, MA, Meddens, SF, Linner, RK, Rietveld, CA, Derringer, J, Gratten, J, Lee, JJ, Liu, JZ, de Vlaming, R, Ahluwalia, TS, Buchwald, J, Cavadino, A, Frazier-Wood, AC, Furlotte, NA, Garfield, V, Geisel, MH, Gonzalez, JR, Haitjema, S, Karlsson, R, van der Laan, SW, Ladwig, KH, Lahti, J, van der Lee, SJ, Lind, PA, Liu, T, Matteson, L, Mihailov, E, Miller, MB, Minica, CC, Nolte, IM, Mook-Kanamori, D, van der Most, PJ, Oldmeadow, C, Qian, Y, Raitakari, O, Rawal, R, Realo, A, Rueedi, R, Schmidt, B, Smith, AV, Stergiakouli, E, Tanaka, T, Taylor, K, Thorleifsson, G, Wedenoja, J, Wellmann, J, Westra, HJ, Willems, SM, Zhao, W, Amin, N, Bakshi, A, Bergmann, S, Bjornsdottir, G, Boyle, PA, Cherney, S, Cox, SR, Davies, G, Davis, OS, Ding, J, Direk, N, Eibich, P, Emeny, RT, Fatemifar, G, Faul, JD, Ferrucci, L, Forstner, AJ, Gieger, C, Gupta, R, Harris, TB, Harris, JM, Holliday, EG Hottenga, JJ, De Jager, PL, Kaakinen, MA, Kajantie, E, Karhunen, V, Kolcic, I, Kumari, M, Launer, LJ, Franke, L, Li-Gao, R, Liewald, DC, Koini, M, Loukola, A, Marques-Vidal, P, Montgomery, GW, Mosing, MA, Paternoster, L, Pattie, A, Petrovic, KE, Pulkki-Raback, L, Quaye, L, Raikkonen, K, Rudan, I, Scott, RJ, Smith, JA, Sutin, AR, Trzaskowski, M, Vinkhuyzen, AE, Yu, L, Zabaneh, D, Attia, JR, Bennett, DA, Berger, K, Bertram, L, Boomsma, DI, Snieder, H, Chang, SC, Cucca, F, Deary, IJ, van Duijn, CM, Eriksson, JG, Bultmann, U, de Geus, EJ, Groenen, PJ, Gudnason, V, Hansen, T, Hartman, CA, Haworth, CM, Hayward, C, Heath, AC, Hinds, DA, Hypponen, E, Iacono, WG, Jarvelin, MR, Jockel, KH, Kaprio, J, Kardia, SL, Keltikangas-Jarvinen, L, Kraft, P, Kubzansky, LD, Lehtimaki, T, Magnusson, PK, Martin, NG, McGue, M, Metspalu, A, Mills, M, de Mutsert, R, Oldehinkel, AJ, Pasterkamp, G, Pedersen, NL, Plomin, R, Polasek, O, Power, C, Rich, SS, Rosendaal, FR, den Ruijter, HM, Schlessinger, D, Schmidt, H, Svento, R, Schmidt, R, Alizadeh, BZ, Sorensen, TI, Spector, TD, Starr, JM, Stefansson, K, Steptoe, A, Terracciano, A, Thorsteinsdottir, U, Thurik, AR, Timpson, NJ, Tiemeier, H, Uitterlinden, AG, Vollenweider, P, Wagner, GG, Weir, DR, Yang, J, Conley, DC, Smith, GD, Hofman, A, Johannesson, M, Laibson, DI, Medland, SE, Meyer, MN, Pickrell, JK, Esko, T, Krueger, RF, Beauchamp, JP, Koellinger, PD, Benjamin, DJ, Bartels, M and Cesarini, D (2016) Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. Nature Genetics 48, 624–633.CrossRefGoogle ScholarPubMed
Pinheiro, AP, Root, T and Bulik, CM (2009) The genetics of Anorexia Nervosa: current findings and future perspectives. International Journal of Child and Adolescent Health 2, 153–164.Google ScholarPubMed
Preti, A, Girolamo, G, Vilagut, G, Alonso, J, Graaf, R, Bruffaerts, R, Demyttenaere, K, Pinto-Meza, A, Haro, JM and Morosini, P (2009) The epidemiology of eating disorders in six European countries: results of the ESEMeD-WMH project. Journal of Psychiatric Research 43, 1125–1132.CrossRefGoogle ScholarPubMed
Purcell, S, Neale, B, Todd-Brown, K, Thomas, L, Ferreira, MA, Bender, D, Maller, J, Sklar, P, de Bakker, PI, Daly, MJ and Sham, PC (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. American Journal of Human Genetics 81, 559–575.CrossRefGoogle ScholarPubMed
Reiterer, M, Schmidt-Kastner, R and Milton, SL (2019) Methionine sulfoxide reductase (Msr) dysfunction in human brain disease. Free Radical Research 53, 1144–1154.CrossRefGoogle ScholarPubMed
Rybakowski, F, Dmitrzak-Weglarz, M, Szczepankiewicz, A, Skibinska, M, Slopien, A, Rajewski, A and Hauser, J (2007) Brain derived neurotrophic factor gene Val66Met and -270C/T polymorphisms and personality traits predisposing to anorexia nervosa. Neuro Endocrinology Letters 28, 153–158.Google ScholarPubMed
Rybakowski, F, Slopien, A, Dmitrzak-Weglarz, M, Czerski, P, Rajewski, A and Hauser, J (2006) The 5-HT2A -1438 A/G and 5-HTTLPR polymorphisms and personality dimensions in adolescent anorexia nervosa: association study. Neuropsychobiology 53, 33–39.CrossRefGoogle ScholarPubMed
Salbach-Andrae, H, Lenz, K, Simmendinger, N, Klinkowski, N, Lehmkuhl, U and Pfeiffer, E (2008) Psychiatric comorbidities among female adolescents with anorexia nervosa. Child Psychiatry and Human Development 39, 261–272.CrossRefGoogle ScholarPubMed
Scherag, A, Dina, C, Hinney, A, Vatin, V, Scherag, S, Vogel, CI, Muller, TD, Grallert, H, Wichmann, HE, Balkau, B, Heude, B, Jarvelin, MR, Hartikainen, AL, Levy-Marchal, C, Weill, J, Delplanque, J, Korner, A, Kiess, W, Kovacs, P, Rayner, NW, Prokopenko, I, McCarthy, MI, Schafer, H, Jarick, I, Boeing, H, Fisher, E, Reinehr, T, Heinrich, J, Rzehak, P, Berdel, D, Borte, M, Biebermann, H, Krude, H, Rosskopf, D, Rimmbach, C, Rief, W, Fromme, T, Klingenspor, M, Schurmann, A, Schulz, N, Nothen, MM, Muhleisen, TW, Erbel, R, Jockel, KH, Moebus, S, Boes, T, Illig, T, Froguel, P, Hebebrand, J and Meyre, D (2010) Two new Loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and German study groups. PLOS Genetics 6, e1000916.CrossRefGoogle Scholar
Serpell, L, Livingstone, A, Neiderman, M and Lask, B (2002) Anorexia nervosa: obsessive-compulsive disorder, obsessive-compulsive personality disorder, or neither? Clinical Psychology Review 22, 647–669.CrossRefGoogle ScholarPubMed
Steiger, H, Richardson, J, Schmitz, N, Joober, R, Israel, M, Bruce, KR, Gauvin, L, Dandurand, C and Anestin, A (2009) Association of trait-defined, eating-disorder sub-phenotypes with (biallelic and triallelic) 5HTTLPR variations. Journal of Psychiatric Research 43, 1086–1094.CrossRefGoogle ScholarPubMed
Swinbourne, JM and Touyz, SW (2007) The co-morbidity of eating disorders and anxiety disorders: a review. European Eating Disorders Review 15, 253–274.CrossRefGoogle ScholarPubMed
Thornton, LM, Mazzeo, SE and Bulik, CM (2011) The heritability of eating disorders: methods and current findings. Current Topics in Behavioral Neurosciences 6, 141–156.CrossRefGoogle ScholarPubMed
Volckmar, AL, Han, CT, Putter, C, Haas, S, Vogel, CI, Knoll, N, Struve, C, Gobel, M, Haas, K, Herrfurth, N, Jarick, I, Grallert, H, Schurmann, A, Al-Hasani, H, Hebebrand, J, Sauer, S and Hinney, A (2016) Analysis of Genes involved in body weight regulation by targeted re-sequencing. PLoS One 11, e0147904.CrossRefGoogle ScholarPubMed
Walss-Bass, C, Soto-Bernardini, MC, Johnson-Pais, T, Leach, RJ, Ontiveros, A, Nicolini, H, Mendoza, R, Jerez, A, Dassori, A, Chavarria-Siles, I, Escamilla, MA and Raventos, H (2009) Methionine sulfoxide reductase: a novel schizophrenia candidate gene. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics 150B, 219–225.CrossRefGoogle ScholarPubMed
Wassef, R, Haenold, R, Hansel, A, Brot, N, Heinemann, SH and Hoshi, T (2007) Methionine sulfoxide reductase A and a dietary supplement S-methyl-L-cysteine prevent Parkinson’s-like symptoms. Journal of Neuroscience 27, 12808–12816.CrossRefGoogle Scholar
Yilmaz, Z, Halvorsen, M, Bryois, J, Yu, D, Thornton, LM, Zerwas, S, Micali, N, Moessner, R, Burton, CL, Zai, G, Erdman, L, Kas, MJ, Arnold, PD, Davis, LK, Knowles, JA, Breen, G, Scharf, JM, Nestadt, G, Mathews, CA, Bulik, CM, Mattheisen, M and Crowley, JJ (2020) Examination of the shared genetic basis of anorexia nervosa and obsessive-compulsive disorder. Molecular Psychiatry 25, 2036–2046.CrossRefGoogle ScholarPubMed
Figure 0

Table 1. Tag-SNPs identified in the region encompassing the MSRA gene

Figure 1

Fig. 1. Overview of the effect of MSRA tag-SNPs on the scores obtained by the Anorexia Nervosa patients in (A) the EDI-2 and (B) SCL-90R inventories. Light color represents a significant association (p < 0.05). Dark color represents a significant association after correction for multiple testing (FDR-q < 0.05). DT, Drive for thinness; B, Bulimia; BD, Body dissatisfaction; I, Inefficacy; P, Perfectionism; ID, Interpersonal Distrust; IA, Interoceptive awareness; MF, Maturity fears; A, Asceticism; IR, Impulse regulation; SI, Social insecurity; GSI, Global severity index; PST, Positive symptom; PSDI, Positive symptom distress index; SOM, Somatization; OC, Obsessive–compulsive; ANX, Anxiety; DEPR, Depression; SENS, Sensitivity; HOST, Hostility; PhANX, Phobic anxiety; PARId, Paranoid ideation; PSYCH, Psychotism; ADD, additional items.

Figure 2

Table 2. Influence of rs814422 on EDI-2 and SCL-90R scores obtained by the patients. Mean values ± standard deviation are shown. Significant values after correction for multiple testing are shown in boldface type

Figure 3

Table 3. Influence of rs11249969 on EDI-2 and SCL-90R scores obtained by the patients. Mean values ± standard deviation are shown. Significant values after correction for multiple testing are shown in boldface type

Figure 4

Fig. 2. Summary of the sliding-window analysis for the association of 3-SNP MSRA haplotypes with the scores obtained by the Anorexia Nervosa patients on eating disorders-related psychopathology measured by the EDI-2 inventory. The dotted line represents the 0.05 adjusted q-level of significance. DT, Drive for thinness; B, Bulimia; BD, Body dissatisfaction; I, Inefficacy; P, Perfectionism; ID, Interpersonal Distrust; IA, Interoceptive awareness; MF, Maturity fears; A, Asceticism; IR, Impulse regulation; SI, Social insecurity.

Figure 5

Fig. 3. Summary of the sliding-window analysis for the association of 3-SNP MSRA haplotypes with the scores obtained by the Anorexia Nervosa patients on general psychopathology measured by the SCL-90R inventory. The dotted line represents the 0.05 adjusted q-level of significance. GSI, Global severity index; PST, Positive symptom; PSDI, Positive symptom distress index; SOM, Somatization; OC, Obsessive–compulsive; ANX, Anxiety; DEPR, Depression; SENS, Sensitivity; HOST, Hostility; PhANX, Phobic anxiety; PARId, Paranoid ideation; PSYCH, Psychotism; ADD, additional items.

Supplementary material: Image

González et al. supplementary material

González et al. supplementary material 1

Download González et al. supplementary material(Image)
Image 1.2 MB
Supplementary material: File

González et al. supplementary material

González et al. supplementary material 2

Download González et al. supplementary material(File)
File 16.2 KB